DH sponsored review of the NHS Homecare Medicines in England
The supply of hospital prescribed medicines direct to patients in their own homes is relatively new. Its correct operational management presents challenges to both the NHS and its commercial partners. The market is expanding and arrangements will have to adapt and develop within a rapidly changing healthcare environment.
To ensure that the Department of Health (DH) fully understands the implications for both patients and the NHS, DH have invited Mark Hackett, CEO, Southampton University Hospitals NHS Trust, to lead a rapid review of Homecare Medicine Supply to consider the current operational arrangements and its future for the best value for patients, the NHS and the provider market.
Immediate enquiries should be directed to homecare@cmu.nhs.uk
Final report
The Homecare Medicines Report – ‘Towards a Vision for the Future’ was published on the 2 December 2011.
“I would like to thank the numerous people who have helped me with this review from those within the Civil Service, the NHS, the Homecare industry and professional associations and the patient representative groups.
We are working on considering the key implementation issues and we will be looking for continued support and engagement.”
Mark Hackett – CEO University Hospital Southampton NHS Foundation Trust
I am grateful to Mark Hackett for leading this work and delivering a comprehensive and important report.
Homecare is an expanding part of healthcare delivery to patients and the public, and is set to grow further. Therefore it is essential it is delivered through robust arrangements that are safe, effective and represent good value for money.
The DH is keen to listen to your views and welcomes any questions or comments that you may have on the report. These should be directed to homecare@cmu.nhs.uk
Dr Keith Ridge, DH Chief Pharmaceutical Officer
Homecare Medicines ‘Towards a vision for the Future (PDF, 2800KB)
